Global Bovine Respiratory Disease Treatment Market Research Report (2021 to 2026) - by Disease Type, Treatment Type, Distribution Channel and Region
DUBLIN, Dec. 15, 2021 /PRNewswire/ -- The "Bovine Respiratory Disease Treatment Market Research Report by Disease Type, Treatment Type, Distribution Channel, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Bovine Respiratory Disease Treatment Market size was estimated at USD 1,590.32 million in 2020, is expected to reach USD 1,702.45 million in 2021, and projected to grow at a CAGR of 7.38% reaching USD 2,439.25 million by 2026.
Market Statistics
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Competitive Strategic Window
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Bovine Respiratory Disease Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Bovine Respiratory Disease Treatment Market, including Bayer AG, Bimeda Inc., Boehringer Ingelheim GmbH, CEVA Animal Health (Pty) Ltd., Elanco Animal Health Incorporated, Krka UK Ltd, Merck & Co. Inc., Merial, Vetoquinol India Animal Health Pvt Ltd, Virbac Group, and Zoetis Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Bovine Respiratory Disease Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bovine Respiratory Disease Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bovine Respiratory Disease Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Bovine Respiratory Disease Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Bovine Respiratory Disease Treatment Market?
6. What is the market share of the leading vendors in the Global Bovine Respiratory Disease Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Bovine Respiratory Disease Treatment Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing prevalence of BRD among cattle
5.2.2. Increasing consumption of beef
5.2.3. Changing environmental factors
5.3. Restraints
5.3.1. Shortage of skilled veterinarians
5.3.2. Increasing cost of animal healthcare
5.4. Opportunities
5.4.1. Increasing focus on research and development of functional therapies
5.4.2. Environmental protection guidelines
5.4.3. Growing awareness among consumers about healthy meat and animal health management
5.5. Challenges
5.5.1. Complexities related to bovine respiratory disease diagnosis
6. Bovine Respiratory Disease Treatment Market, by Disease Type
6.1. Introduction
6.2. Diphtheria
6.3. Pneumonia
6.4. Upper Respiratory Tract Infections
7. Bovine Respiratory Disease Treatment Market, by Treatment Type
7.1. Introduction
7.2. Antibiotics
7.3. Immunomodulators
7.4. Vaccines
8. Bovine Respiratory Disease Treatment Market, by Distribution Channel
8.1. Introduction
8.2. Clinics
8.3. Hospitals
8.4. Research Institutions
9. Americas Bovine Respiratory Disease Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Bovine Respiratory Disease Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Bovine Respiratory Disease Treatment Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Bayer AG
13.2. Bimeda Inc.
13.3. Boehringer Ingelheim GmbH
13.4. CEVA Animal Health (Pty) Ltd.
13.5. Elanco Animal Health Incorporated
13.6. Krka UK Ltd.
13.7. Merck & Co. Inc.
13.8. Merial
13.9. Vetoquinol India Animal Health Pvt Ltd.
13.10. Virbac Group
13.11. Zoetis Inc.
14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/dlyu21
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article